参考文献/References:
[1] Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol, 2005, 45(8): 1243-1248.
[2] Taniguchi R, Koshiyama H, Yamauchi M, et al. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia[J]. Tohoku J Exp Med, 1998, 186(3): 215-223.
[3] Fischer E, Hanslik G, Pallauf A, et al. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy [J]. J Clin Endocrinol Metab, 2012, 97 (11):3965-3973.
[4] Hibi Y, Hayakawa N, Hasegawa M, et al. Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case[J]. Surg Today, 2015, 45(2):241-246.
[5] Funder JW. Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade [J]. Future Cardiol, 2006, 2(5): 535-541.
[6] Preston RA1, Hirsh MJ MD, Oster MD Jr, et al. University of Miami Division of Clinical Pharmacology therapeutic rounds:drug-induced hyperkalemia[J]. Am J Ther, 1998, 5(2): 125-132
[7] Schepkens H, Vanholder R, Billiouw JM, et al. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases[J]. Am J Med, 2001, 110(6): 438-441.
[8] Raebel M. Hyperkalemia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers[J].Cardiovasc Ther, 2012, 30(3): e156-166.
[9] Ben Salem C1, Badreddine A, Fathallah N, et al. Drug-Induced Hyperkalemia[J]. Drug Saf , 2014, 37(9): 677-692